Evidence map›Paper›PMID 38698905›Full record

ArticleFrontiers in cellular and infection microbiology2024

Cellugyrin (synaptogyrin-2) dependent pathways are used by bacterial cytolethal distending toxin and SARS-CoV-2 virus to gain cell entry.

Kathleen Boesze-Battaglia, Gary H Cohen, Paul F Bates, Lisa M Walker, Ali Zekavat, Bruce J Shenker

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kathleen Boesze-BattagliaDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Gary H CohenDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Paul F BatesDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Lisa M WalkerDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Ali ZekavatDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Bruce J ShenkerDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Funding

BACTERIA &LYMPHOCYTE SUPPRESSION IN PERIODONTITISR01DE006014 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI SHENKER, BRUCE J · 1985 to 2021
$8.6M
A. Actinomycetemcomitans Cdt Induces Pro-Inflammatory Innate Immune ResponsesR01DE023071 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI BOESZE-BATTAGLIA, KATHLEEN, SHENKER, BRUCE J · 2013 to 2024
$4.6M
NIDCR NIH HHS R01 DE006014NIDCR NIH HHS R01 DE023071
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ToxinsSARS-CoV-2SynaptogyrinsVirus InternalizationAggregatibacter actinomycetemcomitansAngiotensin-Converting Enzyme 2COVID-19EndocytosisHumansJurkat CellsMembrane MicrodomainsSpike Glycoprotein, CoronavirusACE2 protein, humanAngiotensin-Converting Enzyme 2Bacterial Toxinscytolethal distending toxincytolethal distending toxin, Actinobacillus actinomycetemcomitansSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2SynaptogyrinsAggregatibacter actinomycetemcomitanscell entrycellugyrincytolethal distending toxinpathogenSARS-CoV-2synaptic-like microvesiclessynaptogyrin-2

Identifiers

PMID38698905
PMCPMC11063343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.